Mondelez International, Inc. (MDLZ) › Analysis

Mondelez International, Inc. (MDLZ) analysis, December 23, 2025

Published December 23, 2025 · MDLZ chart, levels and live analysis

Key Updates

Mondelez shares declined 2.19% to $53.84 since the December 19 report, extending losses to five consecutive negative reporting periods. The YTD decline has now reached 9.86%, with the stock trading 21.40% below its 6-month high. The brief recovery documented in the previous report proved short-lived, as shares resumed their downward trajectory. No significant company-specific news emerged during this period, suggesting the decline reflects broader market dynamics and continued pressure from previously identified headwinds including regulatory scrutiny, input cost inflation, and competitive pressures in the snacking category.

Current Trend

Mondelez remains in a confirmed downtrend across all timeframes, with the stock declining 0.87% in the last day, 0.24% over five days, 5.54% over one month, and 21.40% over six months. The YTD loss of 9.86% significantly underperforms the broader market. The current price of $53.84 represents a critical technical juncture, as this level previously served as support in December 10. The stock has failed to establish any meaningful support since breaking down from the mid-$60 range in mid-2025. Trading volume and momentum indicators suggest continued weakness, with no catalyst evident to reverse the bearish sentiment that has dominated since the second half of 2025.

Investment Thesis

The investment thesis for Mondelez centers on its portfolio of global snacking brands, market leadership in chocolate and biscuits, emerging market growth potential, and operational efficiency initiatives. The company's strategic investments in AI-driven marketing through its AIDA platform, which has required over $40 million in investment, represent efforts to modernize consumer engagement and personalize advertising at scale. However, the thesis faces mounting challenges from multiple fronts: escalating input costs driven by climate-related cocoa supply disruptions, regulatory pressure from litigation targeting ultra-processed foods, competitive dynamics from both established players and emerging brands, and potential demand headwinds from GLP-1 weight-loss drugs affecting snacking consumption patterns. The valuation at a forward P/E of 18.28 suggests the market is pricing in these growth concerns and operational headwinds.

Thesis Status

The investment thesis has deteriorated further since the December 19 report. The absence of positive catalysts and continuation of the downtrend indicates persistent fundamental challenges that outweigh the company's strategic initiatives. The BBC's December 13 reporting on "skimpflation" and consumer criticism of Cadbury's Dairy Milk reformulation directly impacts Mondelez's brand equity and pricing power. The ongoing San Francisco litigation against ultra-processed food manufacturers, while not producing new developments this period, continues to represent a material overhang on the sector. Piper Sandler's November 21 price target reduction to $62 with a Neutral rating reflects analyst caution regarding near-term prospects. The company's AI marketing investments and emerging market strategy have yet to translate into stock price appreciation, suggesting execution risk or insufficient magnitude to offset headwinds.

Key Drivers

The primary driver of current weakness remains the absence of positive catalysts to counter established headwinds. Input cost inflation continues to pressure margins, with cocoa prices elevated due to climate-related supply disruptions in Africa, India, Brazil, and Thailand, while dairy costs have increased due to higher feed, fuel, and fertilizer expenses. The company's response through product downsizing and reformulation has generated consumer backlash, with Cadbury's Dairy Milk decreasing 10% in weight while prices increased 48% from December 2021 to December 2025. Regulatory risk persists through the San Francisco lawsuit seeking unspecified damages for healthcare costs related to ultra-processed foods, which could establish precedent for additional municipal actions. Competitive pressures intensified with Unilever's spinoff of its ice cream business targeting snacking sector investors, potentially diverting capital from Mondelez. The company's $40 million investment in AI-driven marketing through AIDA represents a long-term strategic initiative but has not yet demonstrated measurable ROI impact.

Technical Analysis

Mondelez exhibits clear technical weakness with the stock testing the $53.84 support level established on December 10. The 21.40% decline over six months represents a sustained breakdown from the mid-$60 range, with no meaningful support established during this descent. The stock trades below all major moving averages, indicating bearish momentum across short, medium, and long-term timeframes. The 5.54% decline over the past month accelerated the downtrend, while the modest 0.24% loss over five days suggests consolidation at current depressed levels rather than reversal. Volume patterns indicate continued distribution without evidence of institutional accumulation. Key resistance now sits at $55-$56, representing the brief recovery high from December 19, while support at $53.84 appears vulnerable to further breakdown. The absence of positive divergence in momentum indicators suggests additional downside risk before a durable bottom forms.

Bull Case

Bear Case

Get a message when the MDLZ picture changes — the agent team watches the levels and the news for you.Create a free account

More MDLZ analyses